Prophylaxis (HIV)
San Francisco Hospital Wants To Test "Morning After" Treatment
Published in Medical Letter on the CDC and FDA, March 17th, 1997
Within two months, the hospital hopes to win clearances and federal grant money to conduct a trial of the therapy that includes anti-viral drugs AZT and 3TC. The highly effective protease inhibitors, which came into widespread usage in the past year, are not to be included in the study at first.
Participants in the study would be uninfected people who believe they were exposed to HIV within the previous 72 hours during an isolated incident of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- At-Risk Populations
HIV Risk High, Infection Rate Low in Marginalized Populations - Conference Coverage (IUATLD)
Comics, Games, CD-ROMS Teach About TB - Epidemiology
Deaths from AIDS Show First Significant Drop Nationwide - HBV Vaccines
Prenatal Education Boosts Infant Vaccination - Pediatrics
Immunization Numbers Released and Progress Confirmed in Michigan - Chagas Disease
"Cytokine MRNA Levels in Hearts from Strains of Inbred Mice that Develop Different Degrees of Cardiomyopathy After Infection with Trypanosoma cruzi." - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
